Seth Reno - Net Worth and Insider Trading

Seth Reno Net Worth

The estimated net worth of Seth Reno is at least $10 dollars as of 2024-09-20. Seth Reno is the Chief Commercial Officer of NeuroBo Pharmaceuticals Inc and owns about 3 shares of NeuroBo Pharmaceuticals Inc (NRBO) stock worth over $10. Details can be seen in Seth Reno's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Seth Reno has not made any transactions after 2018-02-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Seth Reno

To

Seth Reno Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Seth Reno owns 1 companies in total, including NeuroBo Pharmaceuticals Inc (NRBO) .

Click here to see the complete history of Seth Reno’s form 4 insider trades.

Insider Ownership Summary of Seth Reno

Ticker Comapny Transaction Date Type of Owner
NRBO NeuroBo Pharmaceuticals Inc 2018-02-08 Chief Commercial Officer

Seth Reno Latest Holdings Summary

Seth Reno currently owns a total of 1 stock. Seth Reno owns 3 shares of NeuroBo Pharmaceuticals Inc (NRBO) as of February 8, 2018, with a value of $10.

Latest Holdings of Seth Reno

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NRBO NeuroBo Pharmaceuticals Inc 2018-02-08 3 3.19 10

Holding Weightings of Seth Reno


Seth Reno Form 4 Trading Tracker

According to the SEC Form 4 filings, Seth Reno has made a total of 0 transactions in NeuroBo Pharmaceuticals Inc (NRBO) over the past 5 years. The most-recent trade in NeuroBo Pharmaceuticals Inc is the acquisition of 2 shares on February 8, 2018, which cost Seth Reno around $100,002.

Insider Trading History of Seth Reno

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Seth Reno Trading Performance

GuruFocus tracks the stock performance after each of Seth Reno's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Seth Reno is -9.51%. GuruFocus also compares Seth Reno's trading performance to market benchmark return within the same time period. The performance of stocks bought by Seth Reno within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Seth Reno's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Seth Reno

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 28.64 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 26.68 LIMIT LIMIT LIMIT LIMIT LIMIT

Seth Reno Ownership Network

Ownership Network List of Seth Reno

No Data

Ownership Network Relation of Seth Reno

Insider Network Chart

Seth Reno Owned Company Details

What does NeuroBo Pharmaceuticals Inc do?

Who are the key executives at NeuroBo Pharmaceuticals Inc?

Seth Reno is the Chief Commercial Officer of NeuroBo Pharmaceuticals Inc. Other key executives at NeuroBo Pharmaceuticals Inc include 10 percent owner Dong-a St Co., Ltd , Acting Chief Financial Officer Marshall H Woodworth , and Interim CEO and President Joseph Hooker .

NeuroBo Pharmaceuticals Inc (NRBO) Insider Trades Summary

Over the past 18 months, Seth Reno made no insider transaction in NeuroBo Pharmaceuticals Inc (NRBO). Other recent insider transactions involving NeuroBo Pharmaceuticals Inc (NRBO) include a net purchase of 5,089,060 shares made by Dong-a St Co., Ltd ,

In summary, during the past 3 months, insiders sold 0 shares of NeuroBo Pharmaceuticals Inc (NRBO) in total and bought 5,089,060 shares, with a net purchase of 5,089,060 shares. During the past 18 months, 0 shares of NeuroBo Pharmaceuticals Inc (NRBO) were sold and 5,089,060 shares were bought by its insiders, resulting in a net purchase of 5,089,060 shares.

NeuroBo Pharmaceuticals Inc (NRBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NeuroBo Pharmaceuticals Inc Insider Transactions

No Available Data

Seth Reno Mailing Address

Above is the net worth, insider trading, and ownership report for Seth Reno. You might contact Seth Reno via mailing address: 17199 N. Laurel Park Drive, Suite 401, Livonia Mi 48152.

Discussions on Seth Reno

No discussions yet.